Comment from International Society for Pharmaceutical Engineering (ISPE)

Summary: The International Society for Pharmaceutical Engineering (ISPE) supports the draft guidance but requests specific revisions to clarify requirements and ensure a risk-based approach. They advocate for removing certain administrative burdens, such as requiring signatures on all validated documents or naming a single "response preparer," while suggesting more flexible language regarding investigation plans and executive summaries.